Last reviewed · How we verify
quetiapine fumarate tablets
At a glance
| Generic name | quetiapine fumarate tablets |
|---|---|
| Also known as | Seroquel |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform (PHASE3)
- A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression (PHASE2)
- Long-term Study of FK949E in Elderly Bipolar Disorder Patients (PHASE3)
- Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes (PHASE3)
- A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
- A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard (PHASE1)
- A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia (PHASE1)
- Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- quetiapine fumarate tablets CI brief — competitive landscape report
- quetiapine fumarate tablets updates RSS · CI watch RSS
- AstraZeneca portfolio CI